Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
- Author:
Zhi-Ming LI
1
;
Ying-Jie ZHU
;
Yi XIA
;
Jia-Jia HUANG
;
Wen-Qi JIANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Bleomycin; therapeutic use; Bone Neoplasms; drug therapy; pathology; radiotherapy; Cyclophosphamide; therapeutic use; Dacarbazine; therapeutic use; Disease-Free Survival; Doxorubicin; therapeutic use; Etoposide; therapeutic use; Female; Follow-Up Studies; Hodgkin Disease; drug therapy; pathology; radiotherapy; Humans; Liver Neoplasms; drug therapy; pathology; radiotherapy; Lung Neoplasms; drug therapy; pathology; radiotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; therapeutic use; Procarbazine; therapeutic use; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; therapeutic use; Vincristine; therapeutic use; Young Adult
- From:Chinese Journal of Cancer 2012;31(7):342-347
- CountryChina
- Language:English
- Abstract: Differences between Hodgkin's lymphoma (HL) patients in China and Western countries are known to exist, but data on Chinese patients with HL are limited. It is not clear whether there are clinical and histological differences in patients with HL involving different extranodal sites. This is the first study to analyze Chinese patients with HL involving different extranodal sites. We selected 22 HL patients with extranodal involvement from more than 250 previously untreated HL patients. Most patients were young males, and 20 of the 22 patients had stage IV disease. The major pathologic types were nodular sclerosis classical HL (NSCHL) and mixed cellularity classical HL(MCCHL). At diagnosis, the most commonly involved extranodal sites were the liver and lung, followed by the bones. There was no significant association between the international prognostic score(IPS) and survival in patients with different extranodal sites. Our data showed the overall survival (OS) and disease-free survival (DFS) rates of low-risk group (IPS = 0-2) were relatively higher than those of high-risk group (IPS ≥ 3), but the IPS did not show predictive power for survival. Although HL with extranodal involvement is rare, it should be considered as a unique form of HL.
